摘要目的 通过氯高血红素(Hemin)诱导伊马替尼耐药慢性髓系白血病(CML)细胞株K562/A02-IM 中血红素加氧酶-1(HO-1)基因表达,探讨HO-1基因对伊马替尼耐药CML细胞增殖的影响,为治疗CML多药耐药及新药的开发提供思路和实验依据.方法 采用RT-PCR法检测20例CML伊马替尼耐药患者骨髓细胞中HO-1基因的表达,半定量RT-PCR法和Western blot法分别检测不同剂量Hemin处理K562/A02-IM细胞不同时间后HO-1的表达,通过Annexin V/PI双染色法检测细胞凋亡情况,采用MTT法检测Hemin诱导及锌原卟啉抑制HO-1表达与细胞存活率的关系.结果 RT-PCR结果显示耐药患者骨髓细胞中HO-1基因阳性表达,半定量RT-PCR和Western blot法显示,不同浓度的Hemin(0、10、20及40 μmol/L)处理K562/A02-IM细胞16 h后,HO-1的表达量随Hemin浓度的升高而增加,存在剂量依赖关系,而20 μmol/L Hemin分别处理K562/A02-IM细胞0、8、16、24 h后,HO-1的表达肇在处理16 h组最高.Annexin V/PI法检测显示,0、10、20及40 μmol/L Hemin作用于K562/A02-IM细胞16 h后细胞凋亡率分别为(17.61±0.01)%、(12.13±0.11)%、(7.94±0.03)%和(4.62±0.15)%,其抗凋亡的作用呈剂量依赖性;20 μmol/L Hemin作用K562/A02-IM细胞8、16及24 h的细胞凋亡率分别为(14.72±0.05)%、(8.15±0.07)%和(16.37±0.13)%.MTT法检测显示与对照组相比,Hemin诱导K562/A02-IM细胞HO-1基因表达促进了细胞的增殖,且作用存在剂量依赖关系;而锌原卟啉抑制HO-1的表达,促进了细胞的凋亡(P<0.05).结论 CML伊马替尼耐药患者骨髓细胞HO-1基因阳性表达,HO-1 是一种可诱导表达型基因,具有抗细胞凋亡及促进细胞增殖的作用,抑制HO-1 表达可能成为治疗CML耐药的新方法.

abstractsObjective To investigate the effect of heme oxygenase-1 (HO-1 ) expression on cell growth and apoptosis in imatinib resistant chronic myeloid leukemia (CML) cells ( K562/A02-IM) , and explore the relationship between HO-1 gene and CML. Methods The expression of HO-1 in 20 drug-resistant CML patients was detected by RT-PCR. Different concentrations of hemin were used to induce HO-1 expression of K562/A02-IM, HO-1 expression at different time was detected by RT-PCR and Western blot analysis. Cell apoptosis was detected by Annexin V/PI staining, and MTT assay was used to detect viability of K562/ A02-IM cells after induction or inhibition of HO-1 gene by hemin and zinc protoporphyrin (ZPP). Results RT-PCR showed that HO-1 was expressed in the bone marrow mononuclear cells (BMMNCs). When treated with hemin at different concentrations (0, 10, 20, 40 μmol/L) for 16 h, the expression of HO-1 in K562/ A02-IM was increased in a dose-dependent manner, and peaked at 20 μmol/L of hemin for 16 h. The apoptosis rates were (17.61 ±0.01)%, (12. 13 ±0.11)%, (7.94 ±0.03)% and (4.62 ±0. 15)% at 0,10, 20 and 40 μmol/L of hemin respectively for 16 h and were (14. 7 ± 0.05) % , (8. 1 ± 0. 07) % and (16. 3 ± 0. 13)% at 20 μmol/L of hemin treatment for 8,16, and 24 h respectively. Hemin induced apoptosis of K562/A02-IM cells in a dose-dependent manner. The expression of HO-1 was induced in K562/A02-IM cells in a dose-dependent manner, and the survival of K562/A02-IM cells was significantly increased as compared to that of control group. When HO-1 was inhibited by ZPP, the cells survival was sharply decreased compared to that of the control group (P<0.05). Conclusion HO-1 was expressed in the BMMNCs. It is a kind of molecules whose expression can be induced and can promote the growth of drug-resistant cells. Inhibition of HO-1 expression probably be used for the treatment of drug-resistant CML.